SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001326389-24-000014
Filing Date
2024-02-09
Accepted
2024-02-09 06:53:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 CALIDI BIOTHERAPEUTICS INC 13GA CalidiBiotherapeuticsInc.txt SC 13G/A 5754
  Complete submission text file 0001326389-24-000014.txt   7573
Mailing Address 16 YORK STREET SUITE 2900 TORONTO A6 M5J 0E6
Business Address 16 YORK STREET SUITE 2900 TORONTO A6 M5J 0E6 416-367-4364
Polar Asset Management Partners Inc. (Filed by) CIK: 0001326389 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SC 13G/A

Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Subject) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92875 | Film No.: 24611107
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)